| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HYPE3
|
21.70 | 15.3B | 9.09 | 1.08 | 10.31 | 4.6% | 12.7% | 69 | 40 | 29.75 | +24.8% | 56 | 0.61 |
|
HAPV3
|
6.61 | 3.1B | — | 0.07 | 4.70 | 1.8% | 8.6% | 61 | 64 | 16.52 | +103.5% | 39 | 0.33 |
|
FLRY3
|
19.68 | 10.7B | 16.85 | 2.06 | 6.60 | 9.6% | 15.5% | 60 | 49 | 20.34 | +2.2% | 58 | 1.03 |
|
RDOR3
|
35.18 | 76.7B | 18.31 | 3.88 | 8.19 | 10.5% | 12.5% | 43 | 36 | 23.39 | -24.1% | 50 | 2.65 |
|
RADL3
|
19.60 | 34.3B | 26.16 | 4.67 | 11.62 | 9.4% | 15.6% | 39 | 23 | 9.43 | -37.4% | 57 | 1.18 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.